"
Team:Michigan
From 2012.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{:Team:Michigan/Template: | + | {{:Team:Michigan/Template:New}} |
<html> | <html> | ||
| - | + | <div class="body"> | |
| - | + | <div id="featured"> | |
| - | + | <h3>Sometimes changes need to be made and with that comes a switch; and a terrible pun.</h3> | |
| - | + | <p>Team Michigan is engineering a novel, tightly controlled and inducible protein expression system in Escherichia coli in order to demonstrate that we can create robust boolean genetic control circuits that do not continuously rely on the presence of signaling compounds. We are using two unidirectional recombinases found in pathogenic Escherichia coli, Hbif, and FimE, to manipulate promoter orientation.</p> | |
| - | + | ||
| - | + | </div> | |
| - | + | <div class="slideshow"> | |
| - | + | ||
| - | + | <img src="https://static.igem.org/mediawiki/2012/0/0d/Michigan_%29Random_Team_1.png" alt=""></img> | |
| - | + | ||
| - | + | ||
| - | + | <img src="https://static.igem.org/mediawiki/2012/a/a0/Michigan_Random_Team_2.png" alt=""></img> | |
| - | + | ||
| - | < | + | |
| - | + | <img src="https://static.igem.org/mediawiki/2012/b/bc/Michigan_Random_Team_3.png" alt=""></img> | |
| - | + | ||
| - | </div> | + | </div> |
| + | </div> | ||
</html> | </html> | ||
| Line 26: | Line 27: | ||
<!--- The Mission, Experiments ---> | <!--- The Mission, Experiments ---> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
Revision as of 23:59, 10 September 2012
Sometimes changes need to be made and with that comes a switch; and a terrible pun.
Team Michigan is engineering a novel, tightly controlled and inducible protein expression system in Escherichia coli in order to demonstrate that we can create robust boolean genetic control circuits that do not continuously rely on the presence of signaling compounds. We are using two unidirectional recombinases found in pathogenic Escherichia coli, Hbif, and FimE, to manipulate promoter orientation.
